Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma.
Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma. Cancer Res. 2013 Dec 15; 73(24):7254-64.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Angiogenesis Inhibitors
Animals
Animals
Cell Movement
Cell Movement
Disease Models, Animal
Disease Models, Animal
Humans
Humans
Lymphangiogenesis
Lymphangiogenesis
Lymphoma, Mantle-Cell
Lymphoma, Mantle-Cell
Male
Male
Mice
Mice
Mice, Inbred NOD
Mice, Inbred NOD
Random Allocation
Random Allocation
Thalidomide
Thalidomide
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
Lijun Xia